Valuation of CCDs, CCPS, and Convertible Instruments — Ind AS 109, Ind AS 32, and Option Pricing for Indian Companies

Compulsorily convertible instruments — including Compulsorily Convertible Debentures, Compulsorily Convertible Preference Shares, and warrants — have become the dominant capital structure tool for Indian startups and growth-stage companies raising institutional capital. Mumbai’s private equity ecosystem, its venture debt market, and its concentration of real estate structured finance transactions have made CCD and CCPS structures ubiquitous across the city’s corporate finance landscape. But the valuation of these instruments — both at issuance and for subsequent financial reporting — is significantly more complex than most issuers and their advisors recognise.

Under Ind AS 109 and Ind AS 32, a compulsorily convertible instrument is classified based on whether the conversion terms are fixed or variable. If the instrument converts into a fixed number of shares at a fixed price, it is classified as equity from inception under Ind AS 32, and no ongoing fair value remeasurement is required. If the conversion ratio is variable — for example, converting at a discount to the next round price, or at a price linked to a formula — the embedded derivative must be bifurcated from the debt host and measured at fair value through profit and loss at each reporting date. This is where the complexity and the valuation obligation arise.

How Ind AS 32 and Ind AS 109 Govern CCD and CCPS Valuation in Indian Companies

The valuation of the convertible feature requires an option pricing model — typically a binomial lattice model or Monte Carlo simulation — that captures the conversion probability at each possible future state, the payoff to the holder under conversion versus redemption, and the time value of the optionality. The key inputs are the current equity FMV per share, the conversion price or formula, the expected volatility of the underlying equity, the risk-free rate, and the contractual term. For Mumbai-based companies that have raised convertible instruments in multiple tranches at different conversion terms — as is common in real estate structured finance and tech scale-ups — the aggregate embedded derivative liability on the balance sheet can be material, and its movement drives reported P&L volatility that auditors, incoming investors, and lenders will scrutinise.

For the IBBI Registered Valuer, the CCD or CCPS valuation assignment typically has two components. The first is the valuation of the underlying equity at the reporting date, which feeds directly into the option model. The second is the option model itself, applied to the instrument’s specific terms. Both must be documented with sufficient analytical transparency that the company’s auditors can test and sign off the conclusion, and that an incoming due diligence team can reconstruct the methodology without relying on the valuer’s verbal explanation.

In Mumbai’s private equity and venture debt market — where growth-stage companies regularly raise structured instruments with complex conversion waterfalls — the valuation of these instruments is a compliance requirement at each financial reporting date. Companies that have issued CCDs on the basis of a term sheet and filed them in MCA records without a supporting valuation have a gap in their financial reporting trail that becomes visible and costly when a subsequent investor or acquirer conducts due diligence.

The practical significance of the Ind AS 32 classification for a CCD or CCPS is visible in three specific financial reporting contexts. First, in the balance sheet — a liability-classified instrument increases reported leverage and reduces reported equity, which affects all leverage-based financial ratios that lenders, investors, and rating agencies use to assess creditworthiness. Second, in the P&L — interest on the liability component is recognised as a finance cost regardless of whether cash interest is paid, which reduces reported profit. Third, in the cash flow statement — the repayment of a liability-classified instrument at conversion or redemption is classified as a financing outflow, while the issuance of equity at conversion is treated as a non-cash financing activity. Getting the classification wrong therefore propagates errors across all three primary financial statements simultaneously.

For Mumbai-based financial services companies, technology businesses, and real estate developers that have issued CCDs to PE investors or convertible notes to venture lenders, a review of the Ind AS 32 classification of all outstanding convertible instruments should be a standing item on the CFO’s agenda — not a question that arises only when the auditor raises it during the year-end audit. Early identification of misclassification, with a corrective restatement if necessary, is significantly less disruptive than discovering the error during a financing transaction or a regulatory inspection.

The tax treatment of CCDs in India has become a significant area of litigation and regulatory scrutiny, driven by the income tax department’s increasing focus on thin capitalisation and the reclassification of instruments that appear to be debt but are economically equity. Under the Income Tax Act, interest paid on CCDs is deductible as a business expense in the hands of the issuer, provided the CCD is classified as debt for tax purposes. However, the income tax department has challenged this treatment in numerous cases, arguing that instruments with mandatory conversion into equity should be treated as equity from inception, thereby disallowing the interest deduction and treating the returns as a deemed dividend — which, under the dividend distribution tax regime that applied until 2020, was taxable in the hands of the issuing company rather than the recipient. The abolition of DDT and the shift to recipient-level dividend taxation from FY 2020-21 has changed the calculus, but the fundamental question of whether CCD interest is tax-deductible remains contested.

The transfer pricing dimension of CCD transactions between associated enterprises adds another layer. When a foreign holding company or associated enterprise provides CCD funding to an Indian subsidiary, the terms of the instrument — including the conversion ratio, the coupon, and the conversion trigger — must be at arm’s length under Section 92 of the Income Tax Act. The Transfer Pricing Officer has jurisdiction to examine whether the coupon rate, the conversion terms, and the overall instrument structure reflect what independent parties would have negotiated. CCD instruments that were structured primarily for tax efficiency — low coupon, favorable conversion terms — are particularly vulnerable to transfer pricing adjustment if the arm’s length equivalent would have carried a higher coupon or less favorable conversion economics.

For Mumbai-based companies that have issued CCDs to PE investors, foreign venture capital funds, or overseas holding companies, the regulatory filings at the time of issuance — FC-GPR under FEMA, Form PAS-3 under Companies Act, and intimation to the income tax department — must collectively be consistent in their characterisation of the instrument. Inconsistencies across regulatory filings — where the same instrument is characterised as debt in one filing and equity in another — create a compliance risk that is difficult to remedy retrospectively and that acquirers’ legal teams will identify in due diligence. The IBBI Registered Valuer’s valuation report, which must correctly apply the Ind AS 32 classification principles and the option pricing methodology for the embedded derivative, is the analytical foundation that should drive consistency across all regulatory filings and financial statement presentations.

For further reading on the regulatory framework governing this area, refer to the ICAI guidance on Ind AS 109 — Financial Instruments, which provides the primary regulatory foundation for the analysis discussed here.

Our Valuation for Regulatory Purposes covers the full range of assignments described in this post. If you need professional valuation assistance, we would be pleased to assist. You can reach out to us here or write to harshulmangal.ca@gmail.com.

Regulatory Capital and Balance Sheet Impact of CCD/CCPS Classification

For regulated financial entities — banks, NBFCs, and insurance companies — the Ind AS 32 classification of CCDs and CCPS has direct regulatory capital implications that interact with their statutory capital adequacy reporting. An instrument classified as equity under Ind AS 32 may qualify for inclusion in Tier 1 or Tier 2 regulatory capital under RBI’s Basel III framework, subject to meeting specific criteria related to loss absorption, perpetuity, and discretionary coupon payments. Conversely, an instrument classified as a financial liability under Ind AS 32 is treated as debt for regulatory capital purposes, consuming capital rather than contributing to it. For Mumbai-based NBFCs that have issued CCDs or CCPS to PE investors or foreign holding companies, the alignment between the Ind AS 32 accounting classification and the regulatory capital treatment is a critical compliance dimension that requires coordination between the finance and treasury functions, supported by a well-documented valuation analysis.

The SEBI framework for listed companies adds another layer of complexity for CCPS issued by listed entities. SEBI’s ICDR Regulations specify the pricing floor for CCPS issued by listed companies in public and rights issues, and the conversion ratio must be determined at the time of issuance based on a formula referencing the market price. For CCPS where the conversion ratio is fixed at issuance, the subsequent movement of the underlying equity price relative to the conversion price creates an unrealised gain or loss on the embedded derivative component that flows through the P&L under Ind AS 109. Mumbai-listed companies that have issued CCPS to strategic investors at above-market conversion prices — a structure sometimes used to avoid immediate dilution while securing committed capital — may find that the embedded derivative fair value movements create volatile P&L charges that investors and analysts scrutinise carefully.